Featured 13F manager
Muhlenkamp & Co. Inc.
Wexford, PA 19 processed 13Fs on this site · 2021 Q3–2026 Q2
- $345M
- 28 Positions
- 2026 Q2
- −9.2% QoQ
- Top 5 31.7%
Portfolio
top 5 31.7% · top 10 58.1%
- RUSHA - Rush Enterprises · CL A 7.0%
- NEM - Newmont 6.3%
- AEM - Agnico Eagle Mines 6.2%
- EQT - EQT Corp 6.2%
- MCK - Mckesson 6.0%
- BRK.B - Berkshire Hathaway · CL B 5.6%
- MCHP - Microchip Technology 5.4%
- AAPL - Apple 5.2%
- URI - United Rentals 5.1%
- RGLD - Royal Gold 5.1%
- WAB - Wabtec 4.9%
- BGC - BGC Group · CL A 4.5%
- Other 32.5%
AUM over time
Book
| EQT - EQT Corp | 8.12% | Add +0.4% | 446,292 | $40.75 | $18M | +1,590 | +$3M |
| OXY - Occidental | 6.40% | Add +0.5% | 233,163 | $61.45 | $14M | +1,201 | +$670K |
| MCK - Mckesson | 5.80% | Add +0.8% | 38,209 | $339.87 | $13M | +285 | +$615K |
| UNH - Unitedhealth Group | 5.58% | Add +0.9% | 24,736 | $505.05 | $12M | +212 | −$103K |
| SPDN - Direxion ETF Tr | 5.21% | New | 652,921 | $17.88 | $12M | +652,921 | +$12M |
| SLB - Schlumberger | 5.04% | Add +1.3% | 314,502 | $35.90 | $11M | +3,959 | +$186K |
| RUSHA - Rush Enterprises · CL A | 4.71% | Hold | 240,406 | $43.86 | $11M | — | — |
| CVS - Cvs Health | 4.68% | Add +1.0% | 110,001 | $95.37 | $10M | +1,078 | +$398K |
| AMLP - Alps ETF Tr | 4.64% | Add +1.1% | 284,057 | $36.56 | $10M | +2,957 | +$701K |
| KEX - Kirby | 4.47% | Add +0.4% | 164,549 | $60.77 | $10M | +634 | +$27K |
| BRK.B - Berkshire Hathaway · CL B | 4.46% | Add +0.5% | 37,394 | $267.02 | $10M | +200 | −$170K |
| DOW - DOW Inc | 4.28% | Add +0.4% | 218,157 | $43.93 | $10M | +781 | −$2M |
| BMY - Bristol-Myers Squibb | 4.09% | Add +0.9% | 128,753 | $71.09 | $9M | +1,197 | −$669K |
| Tenneco · CL A | 3.69% | Reduce −14.0% | 475,114 | $17.39 | $8M | −77,055 | −$1M |
| MTZ - Mastec | 3.64% | Add +0.3% | 128,341 | $63.50 | $8M | +446 | −$1M |
| AAPL - Apple | 3.41% | Add 0.0% | 55,322 | $138.21 | $8M | +5 | +$83K |
| MSFT - Microsoft | 3.25% | Add +0.1% | 31,285 | $232.89 | $7M | +44 | −$738K |
| AVGO - Broadcom | 3.19% | Add +0.1% | 16,096 | $444.02 | $7M | +23 | −$661K |
| MCHP - Microchip Technology | 3.06% | Add +0.2% | 112,136 | $61.03 | $7M | +263 | +$346K |
| NMIH - NMI · CL A | 2.67% | Add +0.4% | 293,580 | $20.37 | $6M | +1,052 | +$1M |
| FNV - Franco Nev | 2.04% | Add +8.1% | 38,314 | $119.49 | $5M | +2,861 | −$87K |
| WAB - Wabtec | 2.01% | Add +0.2% | 55,466 | $81.35 | $5M | +91 | −$33K |
| RGLD - Royal Gold | 1.96% | Add +11.3% | 46,855 | $93.82 | $4M | +4,752 | −$100K |
| CCJ - Cameco | 1.92% | Add +0.3% | 162,123 | $26.51 | $4M | +558 | +$902K |
| GLD - Spdr Gold Tr | 1.28% | Add +26.2% | 18,485 | $154.67 | $3M | +3,840 | +$392K |
| EPD - Enterprise Prods Partners L | 0.26% | Hold | 24,855 | $23.78 | $591K | — | — |
| RUSHB - Rush Enterprises · CL B | 0.14% | Hold | 6,507 | $47.95 | $312K | — | — |
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2022 Q2
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| PFE - Pfizer | 0.59% | Exit | 0 | $52.43 | $1M | −24,164 | −$1M |
| MS - Morgan Stanley | 0.38% | Exit | 0 | $76.08 | $822K | −10,805 | −$822K |
Filings history
19 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 28 | $345M | −9.2% | 13F-HR | 8/17/2026 | 000113321926000003 |
| 2026 Q1 | 29 | $380M | +2.2% | 13F-HR | 5/6/2026 | 000113321926000002 |
| 2025 Q4 | 28 | $372M | +1.1% | 13F-HR | 2/4/2026 | 000113321926000001 |
| 2025 Q3 | 31 | $368M | +15.0% | 13F-HR | 11/7/2025 | 000113321925000006 |
| 2025 Q2 | 26 | $320M | +4.6% | 13F-HR | 7/24/2025 | 000113321925000005 |
| 2025 Q1 | 26 | $306M | −7.0% | 13F-HR | 5/13/2025 | 000113321925000004 |
| 2024 Q4 | 30 | $329M | +0.9% | 13F-HR | 2/13/2025 | 000113321925000001 |
| 2024 Q3 | 28 | $326M | +1.9% | 13F-HR | 11/12/2024 | 000113321924000004 |
| 2024 Q2 | 29 | $320M | −7.0% | 13F-HR | 7/17/2024 | 000113321924000003 |
| 2024 Q1 | 29 | $344M | +12.4% | 13F-HR | 4/23/2024 | 000113321924000002 |
| 2023 Q4 | 29 | $306M | +5.5% | 13F-HR | 1/8/2024 | 000113321924000001 |
| 2023 Q3 | 31 | $290M | +2.8% | 13F-HR | 12/6/2023 | 000113321923000005 |
| 2023 Q2 | 31 | $282M | +19.5% | 13F-HR | 7/14/2023 | 000113321923000004 |
| 2022 Q4 | 27 | $236M | +5.4% | 13F-HR | 1/31/2023 | 000113321923000003 |
| 2022 Q3 | 27 | $224M | +4.7% | 13F-HR | 11/1/2022 | 000113321922000004 |
| 2022 Q2 | 28 | $214M | −25.4% | 13F-HR | 7/18/2022 | 000113321922000003 |
| 2022 Q1 | 36 | $287M | 0.0% | 13F-HR | 4/1/2022 | 000113321922000002 |
| 2021 Q4 | 35 | $287M | +10.4% | 13F-HR | 3/29/2022 | 000113321922000001 |
| 2021 Q3 | 32 | $260M | — | 13F-HR | 12/10/2021 | 000113321921000007 |
About
MUHLENKAMP & CO INC
19 processed 13Fs on this site · 2021 Q3–2026 Q2